TY - JOUR T1 - What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer? JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 642 LP - 643 DO - 10.1136/ijgc-2020-002268 VL - 31 IS - 4 AU - Thales Paulo Batista AU - Heng-Cheng Hsu Y1 - 2021/04/01 UR - http://ijgc.bmj.com/content/31/4/642.abstract N2 - ER -